G6PD deficiency is one of the most common genetic diseases. Statistics show that there are up to 400 million people in the world with this disease. So what is G6PD deficiency? Is it dangerous and how should it be detected and treated?

Newborn screening is a program of routine testing for newborns to detect early endocrine and metabolic disorders that affect the health and physical and mental development of children. Below are 3 types of diseases that are screened for newborns by blood tests.

Performing postnatal screening 24-72 hours after birth by taking blood from the baby's heel helps doctors screen for certain genetic diseases and metabolic disorders in children, reducing the number of children with physical and mental retardation and many other diseases.

Heel blood sampling is part of the newborn screening program for babies to detect early endocrine diseases and metabolic disorders that affect the health and physical and mental development of children. Especially dangerous diseases that are difficult to detect clinically at birth.

Prenatal and newborn screening is a measure to help diagnose diseases caused by genetic disorders, thereby providing timely intervention and treatment, limiting the serious consequences caused by congenital malformations, reducing the number of disabled and mentally retarded people in the community, contributing to improving population quality.

Prenatal screening is the use of specific testing methods during pregnancy to diagnose cases of genetic chromosomal disorders in the fetus such as Down syndrome (trisomy 13), Edwards syndrome (trisomy 18) and neural tube defects... So at what week are prenatal screening milestones performed?

Taking blood from the heel and screening newborns within the first 48 hours after birth will help detect birth defects early, preventing serious consequences of birth defects for children.

Newborn screening aims to proactively detect, intervene and treat early diseases, metabolic and genetic disorders during the fetal and neonatal stages. The benefits of newborn screening are to help children develop normally and reduce the number of people with disabilities and intellectual disabilities.

Congenital hypothyroidism is defined as a significant reduction or loss of thyroid function in a newborn baby, affecting the child's growth, physical and mental development. However, if detected and treated early, the child will have the opportunity to develop normally and healthily.

G6PD deficiency is a fairly common genetic enzyme disorder in humans. G6PD deficiency can lead to hemolysis, jaundice, yellow eyes and kidney failure. Newborn screening plays an extremely important role in early detection of the disease for active and effective treatment.

G6PD (Glucose-6-phosphate dehydrogenase) enzyme deficiency is a common disease in humans. Currently, there are about 400 million people in the world with the disease, South Asia is the region with a relatively high incidence rate of 3-5%.